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Reparative radiological changes of hip joint after TNF 
inhibitors in ankylosing spondylitis 
Abstract 
Background: Hip involvement in ankylosing spondylitis (AS) is a common extraspinal 
arthritic manifestation, which is associated to a worse functional outcome. Little data are 
available on the effectiveness of conservative treatment strategies. The TNF inhibitors 
have been proven effective on AS activity parameters. Their structural effect on hip 
disease however, little is studied.  
Case presentation: We describe four new cases of reparative changes of a damaged hip 
joint after treatment with TNF inhibitors. The average of age was 32.5 (27- 36) years. 
There were 3 men and 1 woman. Hip involvement was bilateral in all cases. Etanercept 
was prescribed in 3 cases and infliximab in 1 case. At baseline, all patients had a painful 
and limited hip with high disease activity and an important functional impairment. After an 
average of 5.5 years of treatment with TNF inhibitors, the BASRI hip evaluated in antero-
posterior x-rays of the pelvis remained unchanged at 2.4. The average of mean hip joint 
space was 2.9mm (2.3-3.6). A widening in hip joint space was observed in all cases with 
less subchondral cysts. 
Conclusion: TNF inhibitors seem to be effective on hip joint disease in patients with AS. 
Keywords: Ankylosing Spondylitis, hip, imaging, TNF inhibitors 
Citation: 
Maatallah K, Mahmoud I, Belghali S, et al. Reparative radiological changes of hip joint after TNF 
inhibitors in  ankylosing spondylitis. Caspian J Intern Med 2018; 9(3):303-305. 
 
 
Hip involvement is a common extraspinal arthritic manifestation in patients with 
ankylosing spondylitis (AS) (1). In North Africa, AS occurs in 40% of patients after 10-
year of disease duration (1). Hip replacement surgery in patient with end-stage hip disease 
remains the standard operation. Hip prosthesis has however a limited life span and is not 
devoid from complications (2). Little data are available on the effectiveness of 
conservative treatment strategies. TNF inhibitors have been proven effective on AS 
activity parameters. Their structural effect especially on hip disease is however little 
studied (2). We describe four new cases of reparative changes of a damaged hip joint after 
treatment with TNF inhibitors. Radiological hip progression was assessed using BASRI-h 
(bath ankylosing spondylitis radiographic index of the hip) and the average of hip joint 
space measured at three distinct sites according to Konsta et al. (3).  
 
Case Presentation 
There were 3 men and 1 woman. Hip involvement was bilateral in all cases. Etanercept 
was prescribed in 3 cases and infliximab in 1 case. Demographic, clinical, radiological and 
biologic data at baseline are presented in table 1. At baseline, all patients had a painful and 
limited hips with high disease activity (mean BASDAI (bath ankylosing spondylitis 
activity index) 4.7) (4-6), and an important functional impairment with a mean BASFI 
(bath ankylosing spondylitis functional index) at 6.6 (3.7-9), and a mean index of severity 
for osteoarthritis for the hip (ISH).at 15.6 (11-20) (ISH index entails  three main items 
which more or less include subjective issues like: pain or discomfort, maximum distance 
walking; and activities of daily living).  
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Table 1:  Demographic, clinical and radiographic characteristics of the four cases at baseline 
 Case 1 Case 2 Case 3 Case 4 
Age (years) 37 36 30 27 
Sex M F M M 
Age at onset (years) 23 28 19 17 
Delay in diagnosis (years) 2 1 3 0.25 
Clinical Data 
            ISH 
            BASFI 
            BASDAI 
 
16.5 
 
11 
 
15 
 
20 
9 5.8 3.7 7.6 
6 4.6 4 4.25 
Biological and Radiological data 
         ESR,mean (mm) 
         CRP, mean( mg/l) 
         BASRI hip 
Jo           int space, mean(mm) 
 
44 
 
15 
 
43 
 
78 
49 16 23 45 
2 3 2 2 
2.7 2.2 2.8 2 
AntiTNF alpha treatment Etanercept Infliximab Etanercept Etanercept 
Delay between the first and the last radiograph 4 4 4 10 
ISH: mean index of severity for osteoarthritis for the hip, BASFI: Bath Ankylosing Spondylitis Functional index, BASDAI: Bath Ankylosing Spondylitis 
Activity Index, ESR: Erythrocyte Sedimentation Rate, CRP: C Reactive Protein, BASRI: Bath Ankylosing Spondylitis Radiographic Index 
 
After an average of 5.5 years of treatment with TNF 
inhibitors, analysis of antero-posterior x-rays of the pelvis 
showed a great improvement in disease activity with a 
BASDAI  at 1.5 (0.5-2.8), in functional status with a  mean 
BASFI at 1.6 (0.2-3.3) and a mean  ISH at 2.5 (0-8). The  
 
 
BASRI hip evaluated in antero-posterior x-rays of the pelvis 
performed in same circumstances remained unchanged at 
2.4. The average of mean hip joint space was 2.9mm (2.3-
3.6). A widening in hip joint space was observed in all cases 
with less subchondral cysts (Fig1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Radiographic images of anteroposterior x-rays of the pelvis in 2010 (a) and in 2014 (b) of case 1 showing 
reduction of the space narrowing with less subchondral cysts 
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Discussion 
Because of the central function of the hip joint, 
impairment of hip functioning is associated to a worse 
functional outcome and may seriously worsen prognosis of 
the disease in patients who are usually active and young (4). 
Short-term follow-up studies have suggested a radiographic 
inhibition of the hip under TNF inhibitors (5-7). The long-
term data reported by Konsta et al. have strengthened this 
hypothesis (3).  
Our data, as well as those of literature, suggest that the 
positive effect of TNF inhibitors observed on structural 
changes in patients with rheumatoid arthritis (RA) is also 
seen on osteodestructive changes in patients with AS. In fact, 
unlike the classical structural changes of AS in the spine, 
inflammation of the subchondral bone marrow in the hip (8), 
leads to an erosive disease with joint space narrowing which 
causes joint destruction. Olthough, there is not a new bone 
formation. A similar case of hip radiographic repair after a 
year of infliximab treatment in a patient suffering from SA 
has been reported in the literature (9).  
Radiographic repair of the hip in isolated RA cases have 
also been reported (10-13) including four patients with 
juvenile-onset RA. The mechanisms of improved hip joint 
space have not been studied. Nonetheless, it has a case 
reported by Sakuma et al (13) where it was investigated if 
hip radiographic repair reflected a true histopathological 
repair on the femoral head. This was a juvenile-onset RA 
patient with radiographic improvement in the hip under TNF 
inhibitor. This study showed an eburnated femoral surface 
and partially coated by fibrous tissue. This tissue was 
identified microscopically as fibrocartilage. These findings 
suggest that the x-ray repair could be due to the presence of 
fibrous cartilage overlying a partially repaired joint  
In conclusion, TNF inhibitors seem to be effective on hip 
joint disease in patients with AS. Further studies are however 
required to confirm and evaluate their effect on preventing 
hip impairment. 
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